文献速递临床试验与 GCP真实世界研究与卫生经济

阿片类与非阿片类药物治疗慢性腰背或髋膝骨关节炎疼痛对疼痛相关功能的影响:SPACE随机临床试验

Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
PubMed 文献 · JAMA · 2018-01-01

SPACE实用随机试验纳入240例中度至重度慢性腰背痛或髋膝骨关节炎疼痛患者,比较阿片类与非阿片类药物治疗12个月的效果。结论不支持启动阿片类药物治疗此类慢性疼痛。

要点

  • 阿片类与非阿片类药物治疗12个月疼痛相关功能无显著差异。
  • 非阿片组疼痛强度显著更优,阿片组药物相关症状更常见。
  • 结果不支持对中度至重度慢性腰背或髋膝骨关节炎疼痛启动阿片治疗。

核心结论

  • 阿片类药物治疗12个月在改善疼痛相关功能方面不优于非阿片类药物,且疼痛强度更差、药物相关症状更多。
  • 结果不支持对中度至重度慢性腰背痛或髋膝骨关节炎疼痛启动阿片类药物治疗。

研究设计与样本

  • 实用随机临床试验,12个月随访,盲法结局评估。
  • 从退伍军人事务部初级保健诊所招募,2013年6月至2015年12月入组,2016年12月完成随访。
  • 265例入组,25例随机前退出,240例随机分配;平均年龄58.3岁,女性32例(13.0%)。
  • 234例(97.5%)完成试验。

关键数值与推荐

  • 主要结局为12个月疼痛相关功能(BPI干扰量表,范围0-10,评分越高功能越差),1分改善具有临床重要性。
  • 主要次要结局为疼痛强度(BPI严重度量表,范围0-10,评分越高疼痛越重)。
  • 主要不良结局为药物相关症状(患者报告清单,范围0-19)。
  • 阿片组第一步为即释吗啡、羟考酮或氢可酮/对乙酰氨基酚;非阿片组第一步为对乙酰氨基酚或非甾体抗炎药。
  • 两组均采用目标导向治疗策略,包括3个步骤的多种药物选择,根据个体反应调整。

临床怎么用

  • 对中度至重度慢性腰背痛或髋膝骨关节炎疼痛,不应常规启动阿片类药物治疗。
  • 非阿片类药物在12个月疼痛相关功能上与阿片类相当,且疼痛强度更优、药物相关症状更少。

局限性

  • 试验在退伍军人事务部初级保健诊所进行,人群以男性为主(女性13.0%),外推需谨慎。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Limited evidence is available regarding long-term outcomes of opioids compared with nonopioid medications for chronic pain. OBJECTIVE: To compare opioid vs nonopioid medications over 12 months on pain-related function, pain intensity, and adverse effects. DESIGN, SETTING, AND PARTICIPANTS: Pragmatic, 12-month, randomized trial with masked outcome assessment. Patients were recruited from Veterans Affairs primary care clinics from June 2013 through December 2015; follow-up was completed December 2016. Eligible patients had moderate to severe chronic back pain or hip or knee osteoarthritis pain despite analgesic use. Of 265 patients enrolled, 25 withdrew prior to randomization and 240 were randomized. INTERVENTIONS: Both interventions (opioid and nonopioid medication therapy) followed a treat-to-target strategy aiming for improved pain and function. Each intervention had its own prescribing strategy that included multiple medication options in 3 steps. In the opioid group, the first step was immediate-release morphine, oxycodone, or hydrocodone/acetaminophen. For the nonopioid group, the first step was acetaminophen (paracetamol) or a nonsteroidal anti-inflammatory drug. Medications were changed, added, or adjusted within the assigned treatment group according to individual patient response. MAIN OUTCOMES AND MEASURES: The primary outcome was pain-related function (Brief Pain Inventory [BPI] interference scale) over 12 months and the main secondary outcome was pain intensity (BPI severity scale). For both BPI scales (range, 0-10; higher scores = worse function or pain intensity), a 1-point improvement was clinically important. The primary adverse outcome was medication-related symptoms (patient-reported checklist; range, 0-19). RESULTS: Among 240 randomized patients (mean age, 58.3 years; women, 32 [13.0%]), 234 (97.5%) completed the trial. Groups did not significantly differ on pain-related function over 12 months (overall P = .58); mean 12-month BPI interference was 3.4 for the opioid group and 3.3 for the nonopioid group (difference, 0.1 [95% CI, -0.5 to 0.7]). Pain intensity was significantly better in the nonopioid group over 12 months (overall P = .03); mean 12-month BPI severity was 4.0 for the opioid group and 3.5 for the nonopioid group (difference, 0.5 [95% CI, 0.0 to 1.0]). Adverse medication-related symptoms were significantly more common in the opioid group over 12 months (overall P = .03); mean medication-related symptoms at 12 months were 1.8 in the opioid group and 0.9 in the nonopioid group (difference, 0.9 [95% CI, 0.3 to 1.5]). CONCLUSIONS AND RELEVANCE: Treatment with opioids was not superior to treatment with nonopioid medications for improving pain-related function over 12 months. Results do not support initiation of opioid therapy for moderate to severe chronic back pain or hip or knee osteoarthritis pain. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01583985.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Krebs EE, Gravely A, Nugent S, et al. Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial. JAMA. 2018. PMID: 29509867. doi:10.1001/jama.2018.0899

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。